Mirtazapine Hemihydrate is mainly used to treat major depressive disorder (MDD). It is also used off-label for anxiety, insomnia, and to stimulate appetite and weight gain in underweight or chronically ill patients. Its sedative and anti-nausea effects make it useful in palliative care settings as well. It is grouped under the following drug class(es): Hypnotics and Sedatives. Its therapeutic use is listed as antidepressants and central nervous system (CNS) agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Mirtazapine hydrate and Mirtazapine half-hydrate. Its PubChem CID is 53476253.
Mirtazapine hemihydrate
| CAS No | 341512-89-8 |
|---|---|
| Molecular Formula | C34H40N6O |
| Molecular Weight | 548.70 g/mol |
| Synonyms | bis(5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene);hydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Mirtazapine Hemihydrate is mainly used to treat major depressive disorder (MDD). It is also used off-label for anxiety, insomnia, and to stimulate appetite and weight gain in underweight or chronically ill patients.
The listed CAS number is 341512-89-8.
The listed molecular formula is C34H40N6O.
The listed molecular weight is 548.70 g/mol.
bis(5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene);hydrate.
The source lists Mirtazapine hydrate and Mirtazapine half-hydrate.